NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 176 filers reported holding NEVRO CORP in Q3 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $10,018,800 | -15.0% | 253,000 | 0.0% | 0.00% | -33.3% |
Q3 2022 | $11,790,000 | +6.3% | 253,000 | 0.0% | 0.00% | +50.0% |
Q2 2022 | $11,089,000 | -39.4% | 253,000 | 0.0% | 0.00% | -33.3% |
Q1 2022 | $18,299,000 | -10.8% | 253,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $20,511,000 | -30.3% | 253,000 | 0.0% | 0.00% | -40.0% |
Q3 2021 | $29,444,000 | -29.8% | 253,000 | 0.0% | 0.01% | -28.6% |
Q2 2021 | $41,945,000 | +18.8% | 253,000 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $35,294,000 | +27.4% | 253,000 | +58.1% | 0.01% | +40.0% |
Q4 2020 | $27,696,000 | +24.3% | 160,000 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $22,288,000 | +16.6% | 160,000 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $19,115,000 | +19.5% | 160,000 | 0.0% | 0.01% | 0.0% |
Q1 2020 | $15,997,000 | -14.9% | 160,000 | 0.0% | 0.01% | +25.0% |
Q4 2019 | $18,806,000 | +36.7% | 160,000 | 0.0% | 0.00% | +33.3% |
Q3 2019 | $13,755,000 | +32.6% | 160,000 | 0.0% | 0.00% | +50.0% |
Q2 2019 | $10,373,000 | +3.7% | 160,000 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $10,002,000 | +60.8% | 160,000 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $6,222,000 | -31.8% | 160,000 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $9,120,000 | -28.6% | 160,000 | 0.0% | 0.00% | -33.3% |
Q2 2018 | $12,776,000 | -7.9% | 160,000 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $13,867,000 | +25.5% | 160,000 | 0.0% | 0.00% | +50.0% |
Q4 2017 | $11,046,000 | -24.0% | 160,000 | 0.0% | 0.00% | -33.3% |
Q3 2017 | $14,541,000 | +22.1% | 160,000 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $11,909,000 | -20.6% | 160,000 | 0.0% | 0.00% | -25.0% |
Q1 2017 | $14,992,000 | +55.1% | 160,000 | -36.0% | 0.00% | +33.3% |
Q4 2014 | $9,668,000 | – | 250,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |